Related Experiment Video
Updated: May 27, 2026
A Preclinical Murine Model of Hepatic Metastases
Published on: September 27, 2014
Pancreatic metastasis from renal cell carcinoma
Marielda D'Ambra1, Claudio Ricci, Riccardo Casadei
1Department of Surgery, Sant'Orsola-Malpighi Hospital, Bologna, Italy. marielda.dambra@hotmail.it
Background:
Pancreatic metastases from renal cell carcinoma are uncommon.
Methods:
Retrospective study of 8 patients with a diagnosis of pancreatic metastasis from renal cell carcinoma observed in our Institute.
Results:
Patients were 6 (75%) males and 2 (25%) females. Mean age was 65.3 years. In 5 patients (57.1%), symptoms were present. The median interval of onset from nephrectomy was 10 years. No cases of synchronous pancreatic metastases were observed. Surgical resection was performed in 7 (87.5%) patients. At pathological examination, solitary metastases were identified in 5 patients (71.4%). No post-operative mortality was observed; the morbidity rate was 42.8%. In the group of patients who underwent pancreatic resection, median overall survival was 43.0 months (range 12.9-74.5), median disease-free survival was 23.6 months (range 9.9-74.5).
Conclusions:
Pancreatic metastasis from renal cell carcinoma typically occurs after a long period from the initial nephrectomy, and seems to be related to a good prognosis.
